Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: Endorsement of macrophage polarization

Stem Cells Translational Medicine

Volumn 6, Issue 3, 2017, Pages 1018-1028

  Sicco, Claudia Lo ^a,b   Reverberi, Daniele ^b   Balbi, Carolina ^a   Ulivi, Valentina ^a   Principi, Elisa ^a   Pascucci, Luisa ^c   Becherini, Pamela ^d,e   Bosco, Maria Carla ^d   Varesio, Luigi ^d   Franzin, Chiara ^f   Pozzobon, Michela ^f,g   Cancedda, Ranieri ^a   Tasso, Roberta ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f Fondazione Istituto di Ricerca Pediatrica Città della Speranza   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cell hypoxia; Extracellular vesicles; Inflammation; Macrophages; Mesenchymal stem cells; Regenerative medicine

Indexed keywords

CARDIOTOXIN; ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CELL PROLIFERATION ASSAY; CELL VIABILITY ASSAY; CONTROLLED STUDY; EXOSOME; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MOUSE; MUSCLE INJURY; NONHUMAN; PARACRINE SIGNALING; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DISEASE MODEL; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXTRACELLULAR VESICLES; FLOW CYTOMETRY; INFLAMMATION; MACROPHAGES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 85017552825     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.1002/sctm.16-0363     Document Type: Article

References (50)

1. Goichberg P. Current understanding of the pathways involved in adult stem and progenitor cell migration for tissue homeostasis and repair. Stem Cell Rev 2016; 12:421–437.
2. Gurtner GC, Werner S, Barrandon Y et al. Wound repair and regeneration. Nature 2008; 453:314–321.
3. Velnar T, Bailey T, Smrkolj V. The wound healing process: An overview of the cellular and molecular mechanisms. J Int Med Res 2009;37: 1528–1542.
4. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: Molecular and cellular mechanisms. J Invest Dermatol 2007;127: 514–525.
5. Anghelina M, Krishnan P, Moldovan L et al. Monocytes/macrophages cooperate with progenitor cells During neovascularization and tissue repair: Conversion of cell columns into fibrovascular bundles. Am J Pathol 2006;168:529–541.
6. Lolmede K, Campana L, Vezzoli M et al. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol 2009;85:779–787.
7. Das A, Sinha M, Datta S et al. Monocyte and macrophage plasticity in tissue repair and regeneration. Am J Pathol 2015;185:2596–2606.
8. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair--current views. STEM CELLS 2007; 25:2896–2902.
9. Dimarino AM, Caplan AI, Bonfield TL. Mesenchymal stem cells in tissue repair. Front Immunol 2013;4:201.
10. Ulivi V, Tasso R, Cancedda R et al. Mesenchymal stem cell paracrine activity is modulated by platelet lysate: Induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype. Stem Cells Dev 2014;00: 1–12.
11. Bollini S, Gentili C, Tasso R et al. The regenerative role of the fetal and adult stem cell secretome. J Clin Med 2013;2:302–327.
12. Ratajczak MZ, Kucia M, Jadczyk T et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 2012;26:1166–1173.
13. Tasso R, Ulivi V, Reverberi D et al. In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche. Stem Cells Dev 2013; 22:3178–3191.
14. Bang C, Thum T. Exosomes: New players in cell-cell communication. Int J Biochem Cell Biol 2012;44:2060–2064.
15. Camussi G, Deregibus MC, Bruno S et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78:838–848.
16. Lötvall J, Hill AF, Hochberg F et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 2014;3:26913.
17. Ranganath SH, Levy O, Inamdar MS et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012;10:244–258.
18. De Jong OG, Van Balkom BWM, Schiffelers RM et al. Extracellular vesicles: Potential roles in regenerative medicine. Front Immunol 2014;5:608.
19. Grayson WL, Zhao F, Bunnell B et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007;358:948–953.
20. Martin I, De Boer J, Sensebe L. A relativity concept in mesenchymal stromal cell manufacturing. Cytotherapy 2016;16:613–620.
21. Kholia S, Ranghino A, Garnieri P et al. Extracellular vesicles as new players in angiogenesis. Vasc Pharmacol 2016;S1537–1891: 30105–30101.
22. Valadi H, Ekström K, Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9: 654–659.
23. Lee Y, El Andaloussi S, Wood MJA. Exosomes and microvesicles: Extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012;21:125–134.
24. Zhuang G, Meng C, Guo X et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012;125:2892–2903.
25. Curtale G, Mirolo M, Renzi TA et al. Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA 2013;110: 11499–11504.
26. Sonkoly E, Pivarcsi A. microRNAs in inflammation. Int Rev Immunol 2009;28:535–561.
27. Wang S, Aurora AB, Johnson BA et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261–271.
28. Jia L, Li Y-F, Wu G-F et al. MiRNA-199a- 3p regulates C2C12 myoblast differentiation through IGF-1/AKT/mTOR signal pathway. Int J Mol Sci 2014;15:296–308.
29. Mantovani A, Biswas SK, Galdiero MR et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013;229:176–185.
30. Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol 2013; 93:875–881.
31. Wang H, Melton DW, Porter L et al. Altered macrophage phenotype transition impairs skeletal muscle regeneration. Am J Pathol 2014;184:1167–1184.
32. Chazaud B. Inflammation during skeletal muscle regeneration and tissue remodeling: Application to exercise-induced muscle damage management. Immunol Cell Biol 2016;94:140–145.
33. Shireman PK, Contreras-Shannon V, Reyes-Reyna SM et al. MCP-1 parallels inflammatory and regenerative responses in ischemic muscle. J Surg Res 2006;134:145–157.
34. Folker ES, Baylies MK. Nuclear positioning in muscle development and disease. Front Physiol 2013;4:363.
35. Yãnez-Mo M, Siljander PR-M, Andreu Z et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015;4:27066.
36. Lener T, Gimona M, Aigner L et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles 2015;4:30087.
37. Chen Y, Shao JZ, Xiang LX et al. Mesenchymal stem cells: A promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008;40:815–820.
38. Tasso R, Gaetani M, Molino E et al. The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials 2012;33:2086–2096.
39. White ES, Mantovani AR. Inflammation, wound repair, and fibrosis: Reassessing the spectrum of tissue injury and resolution. J Pathol 2013;229:141–144.
40. Wynn TA, Vanella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 2016;44:450–462.
41. Locati M, Mantovani A, Sica A. Macrophage activation and polarization as an adaptive component of innate immunity. Adv Immunol 2013;120:163–184.
42. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep 2014;6:13.
43. Baglio SR, Rooijers K, Koppers-Lalic D et al. Human bone marrow- and adiposemesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res 2015;6:127.
44. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol 2005;175:6257–6263.
45. Bian S, Zhang L, Duan L et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med. 2014;92:387–397.
46. Maxson S, Lopez EA, Yoo D et al. Concise review: Role of mesenchymal stem cells in wound repair. STEM CELLS TRANSL MED 2012;1: 142–149.
47. Dongdong T, Haojie H, Chuan T et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosomeshuttled let-7b. J Transl Med 2015;13:308–321.
48. Kharraz Y, Guerra J, Mann CJ et al. Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm 2013;2013:491497.
49. Makita N, Hizukuri Y, Yamashiro K et al. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. Int Immunol. 2015;27:131–141.
50. Gondin J, Théret M, Duhamel G et al. Myeloid HIFs are dispensable for resolution of inflammation during skeletal muscle regeneration. J Immunol 2015;194:3389–3399.